Systems pharmacology identifies ajugol-mediated NF-κB/caspase-3 inhibition and isoacteoside-driven p62/mTOR-mediated autophagy as key mechanisms of Rehmanniae Radix and its processed form in Alzheimer’s treatmentHan Xiang, Shuosheng Zhang, Simin Xue et al.|Frontiers in Pharmacology|2025Cited by 2
Investigating the Therapeutic Potential of Rehmanniae Radix and Rehmanniae Radix Praeparata in Alzheimer’s Disease: A Multi-Omics ApproachXiang Han, Jung Hyo Won, Xianglong Meng et al.|Unknown|2024Cited by 0